Xubo Gong

P.R. China
Hangzhou, 310009, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Clinical value of emerging peripheral blood protein biomarkers in prostate cancer (Review).

Clinical value of emerging peripheral blood protein biomarkers in prostate cancer (Review).

Journal: Oncology letters

Published: May 06, 2025

SENP5 acts as a downstream target of androgen receptor and contributes to prostate cancer growth.

SENP5 acts as a downstream target of androgen receptor and contributes to prostate cancer growth.

Journal: Oncology letters

Published: November 19, 2024

Novel natural killer cell-based therapies for hematologic and solid malignancies: latest updates from ASCO 2024.

Novel natural killer cell-based therapies for hematologic and solid malignancies: latest updates from ASCO 2024.

Journal: Journal of hematology & oncology

Published: June 21, 2024

IL1RAP-specific T cell engager depletes acute myeloid leukemia stem cells.

IL1RAP-specific T cell engager depletes acute myeloid leukemia stem cells.

Journal: Journal of hematology & oncology

Published: June 07, 2024

Venetoclax-based therapy for relapsed or refractory acute myeloid leukemia: latest updates from the 2023 ASH annual meeting.

Venetoclax-based therapy for relapsed or refractory acute myeloid leukemia: latest updates from the 2023 ASH annual meeting.

Journal: Experimental hematology & oncology

Published: January 24, 2024

Exosomal miR-222-3p contributes to castration-resistant prostate cancer by activating mTOR signaling.

Exosomal miR-222-3p contributes to castration-resistant prostate cancer by activating mTOR signaling.

Journal: Cancer science

Published: May 23, 2023

Venetoclax-based therapy for relapsed or refractory acute myeloid leukemia: latest updates from the 2022 ASH annual meeting.

Venetoclax-based therapy for relapsed or refractory acute myeloid leukemia: latest updates from the 2022 ASH annual meeting.

Journal: Experimental hematology & oncology

Published: May 04, 2023

Adefovir dipivoxil inhibits APL progression through degradation of the oncoprotein PML-RARA.

Adefovir dipivoxil inhibits APL progression through degradation of the oncoprotein PML-RARA.

Journal: Experimental hematology & oncology

Published: July 28, 2022

Clinical and laboratory characteristics of lymphoid neoplasms in serous effusions: a single centre experience in China.

Clinical and laboratory characteristics of lymphoid neoplasms in serous effusions: a single centre experience in China.

Journal: Diagnostic cytopathology

Published: April 20, 2020

Linalool inhibits the growth of human T cell acute lymphoblastic leukemia cells with involvement of the MAPK signaling pathway.

Linalool inhibits the growth of human T cell acute lymphoblastic leukemia cells with involvement of the MAPK signaling pathway.

Journal: Oncology letters

Published: October 02, 2019

Unusual findings of acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2): A multicenter study.

Unusual findings of acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2): A multicenter study.

Journal: International journal of laboratory hematology

Published: December 13, 2018

Chronic myelogenous leukemia following small lymphocytic lymphoma: a case report and review of literature.

Chronic myelogenous leukemia following small lymphocytic lymphoma: a case report and review of literature.

Journal: International journal of clinical and experimental pathology

Published: August 30, 2018

Showing 1-12 of 16

Last Updated: 09/26/2026